Associated Papers
Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials.
Ishikawa T et al.
Iscience, 2023
37207275 (PubMed )
Supplement: mmc11.xlsx › Sheet1
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.
Barroso-Sousa R et al.
Jco Precision Oncology, 2022
35797509 (PubMed )
Supplement: DS.PO.21.00413.xlsx › Supp_Table_S2
Select a paper to view details